Clinical trial
Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive…
NCT00106821 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00106821 |
|---|---|
| Title | Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease |
| Official title | An 8 Week Randomized, Placebo Controlled, Double-blind Study to Assess the Efficacy of Tiotropium Inhalation Capsules in Patients of African Descent With Chronic Obstructive Pulmonary Disease |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | Tiotropium Bromide Inhalation Powder |
| Enrollment | 166 |
| Start date | Jun 1, 2004 |
| Primary completion | Aug 1, 2005 |
| First posted | Apr 1, 2005 |
| Last update posted | Nov 1, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: